| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $268.8M | — | +24.6% |
| Cost of Revenue | $75.0M | — | +11.5% |
| Gross Profit | $193.8M | — | +30.6% |
| R&D Expense | $88.0M | — | +27.3% |
| SG&A Expense | $58.5M | — | -1.9% |
| Operating Income | -$25.8M | — | +48.0% |
| Pre-tax Income | -$21.9M | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $421.5M | -1.7% | +0.3% |
| Accounts Receivable | $63.4M | +13.2% | +37.7% |
| Current Assets | $600.9M | +1.7% | +8.7% |
| Total Assets | $1.75B | +0.1% | +1.2% |
| Current Liabilities | $135.4M | -20.1% | +17.9% |
| Total Liabilities |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.6M | — | +89.3% |
| Capital Expenditures | $596K | — | -53.9% |
| Investing Cash Flow | -$8.0M | — | -3.2% |
| Financing Cash Flow | $2.2M | — | +472.4% |
| Free Cash Flow | -$2.2M | — | +86.4% |
| +52.6% |
| Income Tax | $951K | — | +306.4% |
| Net Income | -$22.8M | — | +50.8% |
| EPS (Basic) | -$0.24 | — | +52.9% |
| EPS (Diluted) | -$0.24 | — | +52.9% |
| $186.8M |
| -15.0% |
| -31.7% |
| Stockholders' Equity | $1.56B | +2.3% | +7.3% |